ARCHIVES

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

This article is from The Cancer Letter archive.

Vol. 33 No. 6 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Committee Approves NDA For Tamoxifen

January 21, 1977

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

Clearinghouse Exec. Secty, Says It Has Failed in Its Objectives, Recommends It Be Dropped

January 13, 1978

In Brief; NCAB To Hear Report On Human Cancer Virus, Mayo Projects, Proposed FDA Regulations

February 28, 1975

(8-page issue)

November 2, 2002

Centers See Trend To Integrate Control Service With Science

February 18, 1983